ATR and soft tissue neoplasm: ATR-inhibition may not demonstrate TMM-specific efficacy in soft tissue tumors; however, co-treatment of ATR inhibitors with other cytotoxic agents, such as gemcitabine, has proven to be broadly effective by increasing DNA damage in a TMM-independent manner [183].